Thermo Fisher Scientific (TMO) Tops Q2 EPS by 31c
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $613.78 -0.75%
EPS Growth %: +10.7%
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.7%
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $6.03, $0.31 better than the analyst estimate of $5.72. Revenue for the quarter came in at $11.99 billion versus the consensus estimate of $11.71 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
- UBS Starts Internet Initiative Japan Inc (3774:JP) (IIJIY) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
